Emerging treatment strategies for breast cancer brain metastasis: from translational therapeutics to real-world experience

Systemic therapies for primary breast cancer have made great progress over the past two decades. However, oncologists confront an insidious and particularly difficult problem: in those patients with metastatic breast cancer, up to 50% of human epidermal growth factor 2 (HER2)-positive and 25–40% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Ding, Cheng, Hao, Wang, Xin, Vishnoi, Monika, Teh, Bin S., Rostomily, Robert, Chang, Jenny, Wong, Stephen T., Zhao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328353/
https://www.ncbi.nlm.nih.gov/pubmed/32655700
http://dx.doi.org/10.1177/1758835920936151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328353/
https://www.ncbi.nlm.nih.gov/pubmed/32655700
http://dx.doi.org/10.1177/1758835920936151

Ejemplares similares